157 related articles for article (PubMed ID: 9893284)
1. DNA vaccines: vector design, delivery, and antigen presentation.
Feltquate DM
J Cell Biochem Suppl; 1998; 30-31():304-11. PubMed ID: 9893284
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccines: Vector design, delivery, and antigen presentation.
Feltquate DM
J Cell Biochem; 1998; 72(S30-31):304-311. PubMed ID: 29345830
[TBL] [Abstract][Full Text] [Related]
3. Plasmid DNA and viral vector-based vaccines for the treatment of cancer.
Anderson RJ; Schneider J
Vaccine; 2007 Sep; 25 Suppl 2():B24-34. PubMed ID: 17698262
[TBL] [Abstract][Full Text] [Related]
4. Rational design of gene-based vaccines.
Barouch DH
J Pathol; 2006 Jan; 208(2):283-9. PubMed ID: 16362986
[TBL] [Abstract][Full Text] [Related]
5. Flavivirus DNA vaccine with a kick.
Barrett AD
Nat Biotechnol; 2008 May; 26(5):525-6. PubMed ID: 18464782
[No Abstract] [Full Text] [Related]
6. DNA vaccines--challenges in delivery.
Pachuk CJ; McCallus DE; Weiner DB; Satishchandran C
Curr Opin Mol Ther; 2000 Apr; 2(2):188-98. PubMed ID: 11249641
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccination: antigen presentation and the induction of immunity.
Shedlock DJ; Weiner DB
J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
[TBL] [Abstract][Full Text] [Related]
8. Design of plasmid DNA constructs for vaccines.
Montgomery DL; Prather KJ
Methods Mol Med; 2006; 127():11-22. PubMed ID: 16988443
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in mucosal delivery of pDNA vaccines.
Barnes AG; Barnfield C; Brew R; Klavinskis LS
Curr Opin Mol Ther; 2000 Feb; 2(1):87-93. PubMed ID: 11249656
[TBL] [Abstract][Full Text] [Related]
10. Optimization and delivery of plasmid DNA for vaccination.
Jechlinger W
Expert Rev Vaccines; 2006 Dec; 5(6):803-25. PubMed ID: 17184219
[TBL] [Abstract][Full Text] [Related]
11. Targeting the mucosa: genetically engineered vaccines and mucosal immune responses.
Stevceva L; Abimiku AG; Franchini G
Genes Immun; 2000 Jun; 1(5):308-15. PubMed ID: 11196691
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccine design.
Brandsma JL
Methods Mol Med; 2006; 127():3-10. PubMed ID: 16988442
[TBL] [Abstract][Full Text] [Related]
13. Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.
Walcher P; Mayr UB; Azimpour-Tabrizi C; Eko FO; Jechlinger W; Mayrhofer P; Alefantis T; Mujer CV; DelVecchio VG; Lubitz W
Expert Rev Vaccines; 2004 Dec; 3(6):681-91. PubMed ID: 15606353
[TBL] [Abstract][Full Text] [Related]
14. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
[TBL] [Abstract][Full Text] [Related]
15. Use of viral vectors for the development of vaccines.
Liniger M; Zuniga A; Naim HY
Expert Rev Vaccines; 2007 Apr; 6(2):255-66. PubMed ID: 17408374
[TBL] [Abstract][Full Text] [Related]
16. Chemical adjuvants for plasmid DNA vaccines.
Greenland JR; Letvin NL
Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
[TBL] [Abstract][Full Text] [Related]
17. Salmonella-based vaccines for infectious diseases.
Kwon YM; Cox MM; Calhoun LN
Expert Rev Vaccines; 2007 Apr; 6(2):147-52. PubMed ID: 17408365
[TBL] [Abstract][Full Text] [Related]
18. Advances in the development of bacterial vector technology.
Kochi SK; Killeen KP; Ryan US
Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
[TBL] [Abstract][Full Text] [Related]
19. Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems.
Pontes DS; de Azevedo MS; Chatel JM; Langella P; Azevedo V; Miyoshi A
Protein Expr Purif; 2011 Oct; 79(2):165-75. PubMed ID: 21704169
[TBL] [Abstract][Full Text] [Related]
20. Non-viral vector as vaccine carrier.
Chen WC; Huang L
Adv Genet; 2005; 54():315-37. PubMed ID: 16096017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
